+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Nuclear Medicine Software Market - Global Forecast 2026-2032- Product Image
Nuclear Medicine Software Market - Global Forecast 2026-2032- Product Image
Sale

Nuclear Medicine Software Market - Global Forecast 2026-2032

  • Report

  • 190 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6159554
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Nuclear Medicine Software Market is projected to reach USD 1.09 Billion in 2026. It is expected to continue growing at a CAGR of 9.83%, reaching USD 1.92 Billion by 2032.

Nuclear Medicine Software: Executive Overview

Nuclear medicine software supports image acquisition, reconstruction, visualization, quantification, workflow coordination, reporting, and clinical decision-making across diagnostic and therapeutic applications. Its role is expanding as providers seek reproducible interpretation, integrated data exchange, and more efficient use of hybrid imaging modalities. Adoption is shaped by clinical validation, interoperability, cybersecurity, regulatory compliance, and the availability of trained specialists.

Workflow Integration and Quantitative Imaging Reshape the Landscape

The landscape is shifting from standalone workstation tools toward connected platforms that link scanners, picture archiving and communication systems, electronic health records, radiopharmacy workflows, and reporting environments. Quantitative imaging, automated segmentation, dosimetry support, motion correction, protocol standardization, and longitudinal comparison are becoming increasingly important. Vendors and healthcare organizations must also address fragmented data standards, legacy infrastructure, implementation complexity, and the need to demonstrate clinically meaningful improvements rather than merely adding functionality.

Artificial Intelligence Strengthens Automation, Interpretation, and Personalization

Artificial intelligence is influencing nuclear medicine software through automated image reconstruction, noise reduction, lesion detection, organ segmentation, classification, quality assurance, and treatment-response assessment. It can reduce repetitive tasks and help clinicians extract consistent quantitative information from multimodal studies. However, dependable deployment requires representative training data, transparent performance evaluation, human oversight, monitoring for dataset drift, protection of patient information, and regulatory controls. AI is therefore best viewed as an augmentation layer within validated clinical workflows rather than a substitute for specialist judgment.

Regional Dynamics Reflect Uneven Infrastructure and Clinical Maturity

North America benefits from advanced imaging infrastructure, established reimbursement pathways, and strong emphasis on interoperability and clinical validation. Europe shows demand for standardized data exchange, privacy-aware deployment, and cross-border research, while national procurement and regulatory differences affect implementation. Asia-Pacific combines technologically advanced systems in markets such as Japan, South Korea, and Australia with rapidly developing capacity in China and India. Latin America is influenced by uneven access to specialized equipment, workforce constraints, and public-private investment. The Middle East is building specialized healthcare capacity, particularly in GCC countries, while Africa faces infrastructure, maintenance, connectivity, and specialist-availability challenges that make scalable and resilient software especially relevant.

International Groups Shape Standards, Investment, and Adoption Conditions

ASEAN economies present varied levels of healthcare digitization and nuclear medicine capacity, creating demand for adaptable deployment and workforce development. BRICS members span mature, expanding, and resource-constrained systems, with localization and affordability important to implementation. The European Union places strong emphasis on privacy, interoperability, evidence, and coordinated regulation. G7 countries generally have sophisticated clinical infrastructure and rigorous validation expectations, while NATO members may prioritize secure, resilient, and interoperable health information environments. GCC countries are investing in specialized care and digital modernization, creating opportunities for integrated platforms supported by local implementation capabilities.

Country Priorities Range from Advanced Integration to Capacity Building

Australia emphasizes coordinated care, quality assurance, and integration across geographically dispersed services. Brazil and Mexico must address regional disparities, procurement complexity, and specialist access. Canada and the United States focus on interoperability, clinical productivity, data governance, and evidence-based adoption. China and India are expanding advanced imaging capabilities while balancing localization, scale, and workforce requirements. France, Germany, Italy, Spain, and the United Kingdom are shaped by public-sector procurement, privacy obligations, workflow standardization, and pressure to improve efficiency. Japan and South Korea combine advanced technology environments with strong expectations for reliability, integration, and clinically validated automation. Russia’s environment is influenced by domestic infrastructure, supply continuity, and localization considerations.

Prioritize Interoperability, Evidence, and Responsible AI Deployment

Industry leaders should design software around open standards, robust application programming interfaces, and compatibility with existing imaging and clinical systems. They should validate quantitative outputs across institutions and patient populations, document clinical utility, and provide transparent audit trails. AI capabilities should include governance controls, model monitoring, explainable outputs where feasible, and clear escalation to clinicians. Implementation plans should address cybersecurity, downtime resilience, user training, maintenance, and local regulatory requirements. Partnerships with hospitals, academic centers, and professional bodies can help align product development with real workflows while supporting evidence generation and responsible adoption.

Methodology: Evidence-Based Synthesis of Technology and Care Delivery Factors

This executive summary uses a structured qualitative synthesis of the nuclear medicine software domain. The assessment considers software functions, clinical workflows, imaging infrastructure, interoperability requirements, artificial intelligence applications, regulatory and privacy conditions, workforce needs, and regional health-system characteristics. Insights are organized across the specified regions, international groups, and countries, with emphasis on verifiable structural factors rather than unsupported numerical claims. The analysis does not provide market estimates, market shares, forecasts, or company-specific assessments.

Nuclear Medicine Software Advances Through Validated, Connected Workflows

Nuclear medicine software is moving toward integrated, quantitative, and increasingly intelligent clinical environments. The strongest opportunities are linked to solving practical challenges: improving reproducibility, connecting fragmented systems, supporting specialist productivity, and enabling trustworthy analysis across diagnostic and therapeutic pathways. Sustainable progress will depend on demonstrated clinical value, responsible AI governance, cybersecurity, interoperability, and implementation models that reflect the differing capabilities of healthcare systems worldwide.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Nuclear Medicine Software Market, by Product Type
7.1. Introduction
7.2. Nuclear Medicine Analysis Software
7.3. Nuclear Medicine Clinical Decision Support Software
7.4. Nuclear Medicine Data Management Software
7.5. Nuclear Medicine Imaging Software
7.6. Nuclear Medicine Radiation Therapy Software
8. Nuclear Medicine Software Market, by Workflow
8.1. Introduction
8.2. Data Management
8.3. Data Processing
8.4. Image Acquisition
8.5. Reporting
9. Nuclear Medicine Software Market, by Integration
9.1. Introduction
9.2. Integrated
9.3. Standalone
10. Nuclear Medicine Software Market, by Functionality
10.1. Introduction
10.2. Diagnostics
10.3. Therapeutics
11. Nuclear Medicine Software Market, by Deployment Mode
11.1. Introduction
11.2. Cloud Based
11.3. On Premises
12. Nuclear Medicine Software Market, by Application
12.1. Introduction
12.2. Cardiology
12.3. Infectious Diseases
12.4. Neurology
12.5. Oncology
12.5.1. Cancer Staging & Monitoring
12.5.2. Radiation Therapy Planning & Dosimetry
12.5.3. Therapeutic Targeting
12.5.4. Tumor Detection and Diagnosis
12.6. Orthopedics
12.7. Pediatrics
13. Nuclear Medicine Software Market, by End User
13.1. Introduction
13.2. Diagnostic Imaging Centers
13.3. Hospitals
13.4. Research Institutes
14. Nuclear Medicine Software Market, by Region
14.1. Introduction
14.2. Asia-Pacific
14.3. North America
14.4. Latin America
14.5. Europe
14.6. Middle East
14.7. Africa
15. Nuclear Medicine Software Market, by Group
15.1. Introduction
15.2. ASEAN
15.3. GCC
15.4. European Union
15.5. BRICS
15.6. G7
15.7. NATO
16. Nuclear Medicine Software Market, by Country
16.1. Introduction
16.2. United States
16.3. China
16.4. Germany
16.5. United Kingdom
16.6. India
16.7. Japan
16.8. Russia
16.9. Brazil
16.10. Canada
16.11. Italy
16.12. Mexico
16.13. France
16.14. Spain
16.15. Australia
16.16. South Korea
17. Competitive Landscape
17.1. Market Share Analysis, 2025
17.2. Market Concentration Analysis, 2025
17.2.1. Concentration Ratio (CR)
17.2.2. Herfindahl Hirschman Index (HHI)
17.3. Recent Developments & Impact Analysis, 2025
17.4. Product Portfolio Analysis, 2025
17.5. Benchmarking Analysis, 2025
18. Company Profiles
18.1. Bracco Group
18.2. Canon Medical Systems Corporation
18.3. Comecer S.p.A.
18.4. Convergent Imaging Solutions
18.5. ec² Software Solutions
18.6. Esaote S.p.A.
18.7. Gamma Gurus Pty Ltd
18.8. GE Healthcare
18.9. Hermes Medical Solutions, Inc.
18.10. InMed Healthcare
18.11. Koninklijke Philips N.V
18.12. LabLogic Systems Ltd.
18.13. Mediso Medical Imaging Systems
18.14. MIM Software Inc.
18.15. Mirada Medical Ltd. by Sectra AB
18.16. Mirion Technologies Inc.
18.17. Segami Corporation
18.18. Siemens Healthineers AG
18.19. Syntermed Inc.
18.20. Winkgen Medical Systems GmbH & Co. KG
19. Key Experts
LIST OF FIGURES
FIGURE 1. Global Nuclear Medicine Software Market, Years Considered for the Study
FIGURE 2. Global Nuclear Medicine Software Market, Research Design
FIGURE 3. Global Nuclear Medicine Software Market, Research Framework
FIGURE 4. Global Nuclear Medicine Software Market, Data Triangulation
FIGURE 5. Global Nuclear Medicine Software Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Nuclear Medicine Software Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 7. Global Nuclear Medicine Software Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Nuclear Medicine Software Market Size, by Workflow, 2025 vs 2032 (%)
FIGURE 9. Global Nuclear Medicine Software Market Size, by Workflow, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Nuclear Medicine Software Market Size, by Integration, 2025 vs 2032 (%)
FIGURE 11. Global Nuclear Medicine Software Market Size, by Integration, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Nuclear Medicine Software Market Size, by Functionality, 2025 vs 2032 (%)
FIGURE 13. Global Nuclear Medicine Software Market Size, by Functionality, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Nuclear Medicine Software Market Size, by Deployment Mode, 2025 vs 2032 (%)
FIGURE 15. Global Nuclear Medicine Software Market Size, by Deployment Mode, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Nuclear Medicine Software Market Size, by Application, 2025 vs 2032 (%)
FIGURE 17. Global Nuclear Medicine Software Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Nuclear Medicine Software Market Size, by End User, 2025 vs 2032 (%)
FIGURE 19. Global Nuclear Medicine Software Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 20. Global Nuclear Medicine Software Market Size, by Region, 2025 vs 2032 (%)
FIGURE 21. Global Nuclear Medicine Software Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 22. Global Nuclear Medicine Software Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 23. Global Nuclear Medicine Software Market Size, by Country, 2025 vs 2032 (%)
FIGURE 24. Global Nuclear Medicine Software Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 25. Global Nuclear Medicine Software Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Nuclear Medicine Software Market Segmentation & Coverage
TABLE 2. Global Nuclear Medicine Software Market Size, 2017-2032 (USD Million)
TABLE 3. Global Nuclear Medicine Software Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 4. Global Nuclear Medicine Analysis Software Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Nuclear Medicine Analysis Software Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Nuclear Medicine Analysis Software Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Nuclear Medicine Clinical Decision Support Software Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Nuclear Medicine Clinical Decision Support Software Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Nuclear Medicine Clinical Decision Support Software Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Nuclear Medicine Data Management Software Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Nuclear Medicine Data Management Software Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Nuclear Medicine Data Management Software Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Nuclear Medicine Imaging Software Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Nuclear Medicine Imaging Software Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Nuclear Medicine Imaging Software Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Nuclear Medicine Radiation Therapy Software Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Nuclear Medicine Radiation Therapy Software Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Nuclear Medicine Radiation Therapy Software Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Nuclear Medicine Software Market Size, by Workflow, 2017-2032 (USD Million)
TABLE 20. Global Data Management Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Data Management Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Data Management Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Data Processing Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Data Processing Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Data Processing Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Image Acquisition Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global Image Acquisition Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global Image Acquisition Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global Reporting Market Size, by Region, 2017-2032 (USD Million)
TABLE 30. Global Reporting Market Size, by Group, 2017-2032 (USD Million)
TABLE 31. Global Reporting Market Size, by Country, 2017-2032 (USD Million)
TABLE 32. Global Nuclear Medicine Software Market Size, by Integration, 2017-2032 (USD Million)
TABLE 33. Global Integrated Market Size, by Region, 2017-2032 (USD Million)
TABLE 34. Global Integrated Market Size, by Group, 2017-2032 (USD Million)
TABLE 35. Global Integrated Market Size, by Country, 2017-2032 (USD Million)
TABLE 36. Global Standalone Market Size, by Region, 2017-2032 (USD Million)
TABLE 37. Global Standalone Market Size, by Group, 2017-2032 (USD Million)
TABLE 38. Global Standalone Market Size, by Country, 2017-2032 (USD Million)
TABLE 39. Global Nuclear Medicine Software Market Size, by Functionality, 2017-2032 (USD Million)
TABLE 40. Global Diagnostics Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Diagnostics Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Diagnostics Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Therapeutics Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Therapeutics Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Therapeutics Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Nuclear Medicine Software Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 47. Global Cloud Based Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global Cloud Based Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global Cloud Based Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global On Premises Market Size, by Region, 2017-2032 (USD Million)
TABLE 51. Global On Premises Market Size, by Group, 2017-2032 (USD Million)
TABLE 52. Global On Premises Market Size, by Country, 2017-2032 (USD Million)
TABLE 53. Global Nuclear Medicine Software Market Size, by Application, 2017-2032 (USD Million)
TABLE 54. Global Cardiology Market Size, by Region, 2017-2032 (USD Million)
TABLE 55. Global Cardiology Market Size, by Group, 2017-2032 (USD Million)
TABLE 56. Global Cardiology Market Size, by Country, 2017-2032 (USD Million)
TABLE 57. Global Infectious Diseases Market Size, by Region, 2017-2032 (USD Million)
TABLE 58. Global Infectious Diseases Market Size, by Group, 2017-2032 (USD Million)
TABLE 59. Global Infectious Diseases Market Size, by Country, 2017-2032 (USD Million)
TABLE 60. Global Neurology Market Size, by Region, 2017-2032 (USD Million)
TABLE 61. Global Neurology Market Size, by Group, 2017-2032 (USD Million)
TABLE 62. Global Neurology Market Size, by Country, 2017-2032 (USD Million)
TABLE 63. Global Oncology Market Size, by Region, 2017-2032 (USD Million)
TABLE 64. Global Oncology Market Size, by Group, 2017-2032 (USD Million)
TABLE 65. Global Oncology Market Size, by Country, 2017-2032 (USD Million)
TABLE 66. Global Cancer Staging & Monitoring Market Size, by Region, 2017-2032 (USD Million)
TABLE 67. Global Cancer Staging & Monitoring Market Size, by Group, 2017-2032 (USD Million)
TABLE 68. Global Cancer Staging & Monitoring Market Size, by Country, 2017-2032 (USD Million)
TABLE 69. Global Radiation Therapy Planning & Dosimetry Market Size, by Region, 2017-2032 (USD Million)
TABLE 70. Global Radiation Therapy Planning & Dosimetry Market Size, by Group, 2017-2032 (USD Million)
TABLE 71. Global Radiation Therapy Planning & Dosimetry Market Size, by Country, 2017-2032 (USD Million)
TABLE 72. Global Therapeutic Targeting Market Size, by Region, 2017-2032 (USD Million)
TABLE 73. Global Therapeutic Targeting Market Size, by Group, 2017-2032 (USD Million)
TABLE 74. Global Therapeutic Targeting Market Size, by Country, 2017-2032 (USD Million)
TABLE 75. Global Tumor Detection and Diagnosis Market Size, by Region, 2017-2032 (USD Million)
TABLE 76. Global Tumor Detection and Diagnosis Market Size, by Group, 2017-2032 (USD Million)
TABLE 77. Global Tumor Detection and Diagnosis Market Size, by Country, 2017-2032 (USD Million)
TABLE 78. Global Orthopedics Market Size, by Region, 2017-2032 (USD Million)
TABLE 79. Global Orthopedics Market Size, by Group, 2017-2032 (USD Million)
TABLE 80. Global Orthopedics Market Size, by Country, 2017-2032 (USD Million)
TABLE 81. Global Pediatrics Market Size, by Region, 2017-2032 (USD Million)
TABLE 82. Global Pediatrics Market Size, by Group, 2017-2032 (USD Million)
TABLE 83. Global Pediatrics Market Size, by Country, 2017-2032 (USD Million)
TABLE 84. Global Nuclear Medicine Software Market Size, by End User, 2017-2032 (USD Million)
TABLE 85. Global Diagnostic Imaging Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 86. Global Diagnostic Imaging Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 87. Global Diagnostic Imaging Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 88. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 89. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 90. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 91. Global Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 92. Global Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 93. Global Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 94. Global Nuclear Medicine Software Market Size, by Region, 2017-2032 (USD Million)
TABLE 95. Asia-Pacific Nuclear Medicine Software Market Size, by Region, 2017-2032 (USD Million)
TABLE 96. Asia-Pacific Nuclear Medicine Software Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 97. Asia-Pacific Nuclear Medicine Software Market Size, by Workflow, 2017-2032 (USD Million)
TABLE 98. Asia-Pacific Nuclear Medicine Software Market Size, by Integration, 2017-2032 (USD Million)
TABLE 99. Asia-Pacific Nuclear Medicine Software Market Size, by Functionality, 2017-2032 (USD Million)
TABLE 100. Asia-Pacific Nuclear Medicine Software Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 101. Asia-Pacific Nuclear Medicine Software Market Size, by Application, 2017-2032 (USD Million)
TABLE 102. Asia-Pacific Nuclear Medicine Software Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 103. Asia-Pacific Nuclear Medicine Software Market Size, by End User, 2017-2032 (USD Million)
TABLE 104. North America Nuclear Medicine Software Market Size, by Region, 2017-2032 (USD Million)
TABLE 105. North America Nuclear Medicine Software Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 106. North America Nuclear Medicine Software Market Size, by Workflow, 2017-2032 (USD Million)
TABLE 107. North America Nuclear Medicine Software Market Size, by Integration, 2017-2032 (USD Million)
TABLE 108. North America Nuclear Medicine Software Market Size, by Functionality, 2017-2032 (USD Million)
TABLE 109. North America Nuclear Medicine Software Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 110. North America Nuclear Medicine Software Market Size, by Application, 2017-2032 (USD Million)
TABLE 111. North America Nuclear Medicine Software Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 112. North America Nuclear Medicine Software Market Size, by End User, 2017-2032 (USD Million)
TABLE 113. Latin America Nuclear Medicine Software Market Size, by Region, 2017-2032 (USD Million)
TABLE 114. Latin America Nuclear Medicine Software Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 115. Latin America Nuclear Medicine Software Market Size, by Workflow, 2017-2032 (USD Million)
TABLE 116. Latin America Nuclear Medicine Software Market Size, by Integration, 2017-2032 (USD Million)
TABLE 117. Latin America Nuclear Medicine Software Market Size, by Functionality, 2017-2032 (USD Million)
TABLE 118. Latin America Nuclear Medicine Software Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 119. Latin America Nuclear Medicine Software Market Size, by Application, 2017-2032 (USD Million)
TABLE 120. Latin America Nuclear Medicine Software Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 121. Latin America Nuclear Medicine Software Market Size, by End User, 2017-2032 (USD Million)
TABLE 122. Europe Nuclear Medicine Software Market Size, by Region, 2017-2032 (USD Million)
TABLE 123. Europe Nuclear Medicine Software Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 124. Europe Nuclear Medicine Software Market Size, by Workflow, 2017-2032 (USD Million)
TABLE 125. Europe Nuclear Medicine Software Market Size, by Integration, 2017-2032 (USD Million)
TABLE 126. Europe Nuclear Medicine Software Market Size, by Functionality, 2017-2032 (USD Million)
TABLE 127. Europe Nuclear Medicine Software Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 128. Europe Nuclear Medicine Software Market Size, by Application, 2017-2032 (USD Million)
TABLE 129. Europe Nuclear Medicine Software Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 130. Europe Nuclear Medicine Software Market Size, by End User, 2017-2032 (USD Million)
TABLE 131. Middle East Nuclear Medicine Software Market Size, by Region, 2017-2032 (USD Million)
TABLE 132. Middle East Nuclear Medicine Software Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 133. Middle East Nuclear Medicine Software Market Size, by Workflow, 2017-2032 (USD Million)
TABLE 134. Middle East Nuclear Medicine Software Market Size, by Integration, 2017-2032 (USD Million)
TABLE 135. Middle East Nuclear Medicine Software Market Size, by Functionality, 2017-2032 (USD Million)
TABLE 136. Middle East Nuclear Medicine Software Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 137. Middle East Nuclear Medicine Software Market Size, by Application, 2017-2032 (USD Million)
TABLE 138. Middle East Nuclear Medicine Software Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 139. Middle East Nuclear Medicine Software Market Size, by End User, 2017-2032 (USD Million)
TABLE 140. Africa Nuclear Medicine Software Market Size, by Region, 2017-2032 (USD Million)
TABLE 141. Africa Nuclear Medicine Software Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 142. Africa Nuclear Medicine Software Market Size, by Workflow, 2017-2032 (USD Million)
TABLE 143. Africa Nuclear Medicine Software Market Size, by Integration, 2017-2032 (USD Million)
TABLE 144. Africa Nuclear Medicine Software Market Size, by Functionality, 2017-2032 (USD Million)
TABLE 145. Africa Nuclear Medicine Software Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 146. Africa Nuclear Medicine Software Market Size, by Application, 2017-2032 (USD Million)
TABLE 147. Africa Nuclear Medicine Software Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 148. Africa Nuclear Medicine Software Market Size, by End User, 2017-2032 (USD Million)
TABLE 149. Global Nuclear Medicine Software Market Size, by Group, 2017-2032 (USD Million)
TABLE 150. ASEAN Nuclear Medicine Software Market Size, by Group, 2017-2032 (USD Million)
TABLE 151. ASEAN Nuclear Medicine Software Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 152. ASEAN Nuclear Medicine Software Market Size, by Workflow, 2017-2032 (USD Million)
TABLE 153. ASEAN Nuclear Medicine Software Market Size, by Integration, 2017-2032 (USD Million)
TABLE 154. ASEAN Nuclear Medicine Software Market Size, by Functionality, 2017-2032 (USD Million)
TABLE 155. ASEAN Nuclear Medicine Software Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 156. ASEAN Nuclear Medicine Software Market Size, by Application, 2017-2032 (USD Million)
TABLE 157. ASEAN Nuclear Medicine Software Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 158. ASEAN Nuclear Medicine Software Market Size, by End User, 2017-2032 (USD Million)
TABLE 159. GCC Nuclear Medicine Software Market Size, by Group, 2017-2032 (USD Million)
TABLE 160. GCC Nuclear Medicine Software Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 161. GCC Nuclear Medicine Software Market Size, by Workflow, 2017-2032 (USD Million)
TABLE 162. GCC Nuclear Medicine Software Market Size, by Integration, 2017-2032 (USD Million)
TABLE 163. GCC Nuclear Medicine Software Market Size, by Functionality, 2017-2032 (USD Million)
TABLE 164. GCC Nuclear Medicine Software Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 165. GCC Nuclear Medicine Software Market Size, by Application, 2017-2032 (USD Million)
TABLE 166. GCC Nuclear Medicine Software Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 167. GCC Nuclear Medicine Software Market Size, by End User, 2017-2032 (USD Million)
TABLE 168. European Union Nuclear Medicine Software Market Size, by Group, 2017-2032 (USD Million)
TABLE 169. European Union Nuclear Medicine Software Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 170. European Union Nuclear Medicine Software Market Size, by Workflow, 2017-2032 (USD Million)
TABLE 171. European Union Nuclear Medicine Software Market Size, by Integration, 2017-2032 (USD Million)
TABLE 172. European Union Nuclear Medicine Software Market Size, by Functionality, 2017-2032 (USD Million)
TABLE 173. European Union Nuclear Medicine Software Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 174. European Union Nuclear Medicine Software Market Size, by Application, 2017-2032 (USD Million)
TABLE 175. European Union Nuclear Medicine Software Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 176. European Union Nuclear Medicine Software Market Size, by End User, 2017-2032 (USD Million)
TABLE 177. BRICS Nuclear Medicine Software Market Size, by Group, 2017-2032 (USD Million)
TABLE 178. BRICS Nuclear Medicine Software Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 179. BRICS Nuclear Medicine Software Market Size, by Workflow, 2017-2032 (USD Million)
TABLE 180. BRICS Nuclear Medicine Software Market Size, by Integration, 2017-2032 (USD Million)
TABLE 181. BRICS Nuclear Medicine Software Market Size, by Functionality, 2017-2032 (USD Million)
TABLE 182. BRICS Nuclear Medicine Software Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 183. BRICS Nuclear Medicine Software Market Size, by Application, 2017-2032 (USD Million)
TABLE 184. BRICS Nuclear Medicine Software Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 185. BRICS Nuclear Medicine Software Market Size, by End User, 2017-2032 (USD Million)
TABLE 186. G7 Nuclear Medicine Software Market Size, by Group, 2017-2032 (USD Million)
TABLE 187. G7 Nuclear Medicine Software Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 188. G7 Nuclear Medicine Software Market Size, by Workflow, 2017-2032 (USD Million)
TABLE 189. G7 Nuclear Medicine Software Market Size, by Integration, 2017-2032 (USD Million)
TABLE 190. G7 Nuclear Medicine Software Market Size, by Functionality, 2017-2032 (USD Million)
TABLE 191. G7 Nuclear Medicine Software Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 192. G7 Nuclear Medicine Software Market Size, by Application, 2017-2032 (USD Million)
TABLE 193. G7 Nuclear Medicine Software Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 194. G7 Nuclear Medicine Software Market Size, by End User, 2017-2032 (USD Million)
TABLE 195. NATO Nuclear Medicine Software Market Size, by Group, 2017-2032 (USD Million)
TABLE 196. NATO Nuclear Medicine Software Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 197. NATO Nuclear Medicine Software Market Size, by Workflow, 2017-2032 (USD Million)
TABLE 198. NATO Nuclear Medicine Software Market Size, by Integration, 2017-2032 (USD Million)
TABLE 199. NATO Nuclear Medicine Software Market Size, by Functionality, 2017-2032 (USD Million)
TABLE 200. NATO Nuclear Medicine Software Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 201. NATO Nuclear Medicine Software Market Size, by Application, 2017-2032 (USD Million)
TABLE 202. NATO Nuclear Medicine Software Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 203. NATO Nuclear Medicine Software Market Size, by End User, 2017-2032 (USD Million)
TABLE 204. Global Nuclear Medicine Software Market Size, by Country, 2017-2032 (USD Million)
TABLE 205. United States Nuclear Medicine Software Market Size, 2017-2032 (USD Million)
TABLE 206. United States Nuclear Medicine Software Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 207. United States Nuclear Medicine Software Market Size, by Workflow, 2017-2032 (USD Million)
TABLE 208. United States Nuclear Medicine Software Market Size, by Integration, 2017-2032 (USD Million)
TABLE 209. United States Nuclear Medicine Software Market Size, by Functionality, 2017-2032 (USD Million)
TABLE 210. United States Nuclear Medicine Software Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 211. United States Nuclear Medicine Software Market Size, by Application, 2017-2032 (USD Million)
TABLE 212. United States Nuclear Medicine Software Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 213. United States Nuclear Medicine Software Market Size, by End User, 2017-2032 (USD Million)
TABLE 214. China Nuclear Medicine Software Market Size, 2017-2032 (USD Million)
TABLE 215. China Nuclear Medicine Software Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 216. China Nuclear Medicine Software Market Size, by Workflow, 2017-2032 (USD Million)
TABLE 217. China Nuclear Medicine Software Market Size, by Integration, 2017-2032 (USD Million)
TABLE 218. China Nuclear Medicine Software Market Size, by Functionality, 2017-2032 (USD Million)
TABLE 219. China Nuclear Medicine Software Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 220. China Nuclear Medicine Software Market Size, by Application, 2017-2032 (USD Million)
TABLE 221. China Nuclear Medicine Software Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 222. China Nuclear Medicine Software Market Size, by End User, 2017-2032 (USD Million)
TABLE 223. Germany Nuclear Medicine Software Market Size, 2017-2032 (USD Million)
TABLE 224. Germany Nuclear Medicine Software Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 225. Germany Nuclear Medicine Software Market Size, by Workflow, 2017-2032 (USD Million)
TABLE 226. Germany Nuclear Medicine Software Market Size, by Integration, 2017-2032 (USD Million)
TABLE 227. Germany Nuclear Medicine Software Market Size, by Functionality, 2017-2032 (USD Million)
TABLE 228. Germany Nuclear Medicine Software Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 229. Germany Nuclear Medicine Software Market Size, by Application, 2017-2032 (USD Million)
TABLE 230. Germany Nuclear Medicine Software Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 231. Germany Nuclear Medicine Software Market Size, by End User, 2017-2032 (USD Million)
TABLE 232. United Kingdom Nuclear Medicine Software Market Size, 2017-2032 (USD Million)
TABLE 233. United Kingdom Nuclear Medicine Software Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 234. United Kingdom Nuclear Medicine Software Market Size, by Workflow, 2017-2032 (USD Million)
TABLE 235. United Kingdom Nuclear Medicine Software Market Size, by Integration, 2017-2032 (USD Million)
TABLE 236. United Kingdom Nuclear Medicine Software Market Size, by Functionality, 2017-2032 (USD Million)
TABLE 237. United Kingdom Nuclear Medicine Software Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 238. United Kingdom Nuclear Medicine Software Market Size, by Application, 2017-2032 (USD Million)
TABLE 239. United Kingdom Nuclear Medicine Software Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 240. United Kingdom Nuclear Medicine Software Market Size, by End User, 2017-2032 (USD Million)
TABLE 241. India Nuclear Medicine Software Market Size, 2017-2032 (USD Million)
TABLE 242. India Nuclear Medicine Software Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 243. India Nuclear Medicine Software Market Size, by Workflow, 2017-2032 (USD Million)
TABLE 244. India Nuclear Medicine Software Market Size, by Integration, 2017-2032 (USD Million)
TABLE 245. India Nuclear Medicine Software Market Size, by Functionality, 2017-2032 (USD Million)
TABLE 246. India Nuclear Medicine Software Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 247. India Nuclear Medicine Software Market Size, by Application, 2017-2032 (USD Million)
TABLE 248. India Nuclear Medicine Software Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 249. India Nuclear Medicine Software Market Size, by End User, 2017-2032 (USD Million)
TABLE 250. Japan Nuclear Medicine Software Market Size, 2017-2032 (USD Million)
TABLE 251. Japan Nuclear Medicine Software Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 252. Japan Nuclear Medicine Software Market Size, by Workflow, 2017-2032 (USD Million)
TABLE 253. Japan Nuclear Medicine Software Market Size, by Integration, 2017-2032 (USD Million)
TABLE 254. Japan Nuclear Medicine Software Market Size, by Functionality, 2017-2032 (USD Million)
TABLE 255. Japan Nuclear Medicine Software Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 256. Japan Nuclear Medicine Software Market Size, by Application, 2017-2032 (USD Million)
TABLE 257. Japan Nuclear Medicine Software Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 258. Japan Nuclear Medicine Software Market Size, by End User, 2017-2032 (USD Million)
TABLE 259. Russia Nuclear Medicine Software Market Size, 2017-2032 (USD Million)
TABLE 260. Russia Nuclear Medicine Software Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 261. Russia Nuclear Medicine Software Market Size, by Workflow, 2017-2032 (USD Million)
TABLE 262. Russia Nuclear Medicine Software Market Size, by Integration, 2017-2032 (USD Million)
TABLE 263. Russia Nuclear Medicine Software Market Size, by Functionality, 2017-2032 (USD Million)
TABLE 264. Russia Nuclear Medicine Software Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 265. Russia Nuclear Medicine Software Market Size, by Application, 2017-2032 (USD Million)
TABLE 266. Russia Nuclear Medicine Software Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 267. Russia Nuclear Medicine Software Market Size, by End User, 2017-2032 (USD Million)
TABLE 268. Brazil Nuclear Medicine Software Market Size, 2017-2032 (USD Million)
TABLE 269. Brazil Nuclear Medicine Software Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 270. Brazil Nuclear Medicine Software Market Size, by Workflow, 2017-2032 (USD Million)
TABLE 271. Brazil Nuclear Medicine Software Market Size, by Integration, 2017-2032 (USD Million)
TABLE 272. Brazil Nuclear Medicine Software Market Size, by Functionality, 2017-2032 (USD Million)
TABLE 273. Brazil Nuclear Medicine Software Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 274. Brazil Nuclear Medicine Software Market Size, by Application, 2017-2032 (USD Million)
TABLE 275. Brazil Nuclear Medicine Software Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 276. Brazil Nuclear Medicine Software Market Size, by End User, 2017-2032 (USD Million)
TABLE 277. Canada Nuclear Medicine Software Market Size, 2017-2032 (USD Million)
TABLE 278. Canada Nuclear Medicine Software Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 279. Canada Nuclear Medicine Software Market Size, by Workflow, 2017-2032 (USD Million)
TABLE 280. Canada Nuclear Medicine Software Market Size, by Integration, 2017-2032 (USD Million)
TABLE 281. Canada Nuclear Medicine Software Market Size, by Functionality, 2017-2032 (USD Million)
TABLE 282. Canada Nuclear Medicine Software Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 283. Canada Nuclear Medicine Software Market Size, by Application, 2017-2032 (USD Million)
TABLE 284. Canada Nuclear Medicine Software Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 285. Canada Nuclear Medicine Software Market Size, by End User, 2017-2032 (USD Million)
TABLE 286. Italy Nuclear Medicine Software Market Size, 2017-2032 (USD Million)
TABLE 287. Italy Nuclear Medicine Software Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 288. Italy Nuclear Medicine Software Market Size, by Workflow, 2017-2032 (USD Million)
TABLE 289. Italy Nuclear Medicine Software Market Size, by Integration, 2017-2032 (USD Million)
TABLE 290. Italy Nuclear Medicine Software Market Size, by Functionality, 2017-2032 (USD Million)
TABLE 291. Italy Nuclear Medicine Software Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 292. Italy Nuclear Medicine Software Market Size, by Application, 2017-2032 (USD Million)
TABLE 293. Italy Nuclear Medicine Software Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 294. Italy Nuclear Medicine Software Market Size, by End User, 2017-2032 (USD Million)
TABLE 295. Mexico Nuclear Medicine Software Market Size, 2017-2032 (USD Million)
TABLE 296. Mexico Nuclear Medicine Software Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 297. Mexico Nuclear Medicine Software Market Size, by Workflow, 2017-2032 (USD Million)
TABLE 298. Mexico Nuclear Medicine Software Market Size, by Integration, 2017-2032 (USD Million)
TABLE 299. Mexico Nuclear Medicine Software Market Size, by Functionality, 2017-2032 (USD Million)
TABLE 300. Mexico Nuclear Medicine Software Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 301. Mexico Nuclear Medicine Software Market Size, by Application, 2017-2032 (USD Million)
TABLE 302. Mexico Nuclear Medicine Software Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 303. Mexico Nuclear Medicine Software Market Size, by End User, 2017-2032 (USD Million)
TABLE 304. France Nuclear Medicine Software Market Size, 2017-2032 (USD Million)
TABLE 305. France Nuclear Medicine Software Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 306. France Nuclear Medicine Software Market Size, by Workflow, 2017-2032 (USD Million)
TABLE 307. France Nuclear Medicine Software Market Size, by Integration, 2017-2032 (USD Million)
TABLE 308. France Nuclear Medicine Software Market Size, by Functionality, 2017-2032 (USD Million)
TABLE 309. France Nuclear Medicine Software Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 310. France Nuclear Medicine Software Market Size, by Application, 2017-2032 (USD Million)
TABLE 311. France Nuclear Medicine Software Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 312. France Nuclear Medicine Software Market Size, by End User, 2017-2032 (USD Million)
TABLE 313. Spain Nuclear Medicine Software Market Size, 2017-2032 (USD Million)
TABLE 314. Spain Nuclear Medicine Software Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 315. Spain Nuclear Medicine Software Market Size, by Workflow, 2017-2032 (USD Million)
TABLE 316. Spain Nuclear Medicine Software Market Size, by Integration, 2017-2032 (USD Million)
TABLE 317. Spain Nuclear Medicine Software Market Size, by Functionality, 2017-2032 (USD Million)
TABLE 318. Spain Nuclear Medicine Software Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 319. Spain Nuclear Medicine Software Market Size, by Application, 2017-2032 (USD Million)
TABLE 320. Spain Nuclear Medicine Software Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 321. Spain Nuclear Medicine Software Market Size, by End User, 2017-2032 (USD Million)
TABLE 322. Australia Nuclear Medicine Software Market Size, 2017-2032 (USD Million)
TABLE 323. Australia Nuclear Medicine Software Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 324. Australia Nuclear Medicine Software Market Size, by Workflow, 2017-2032 (USD Million)
TABLE 325. Australia Nuclear Medicine Software Market Size, by Integration, 2017-2032 (USD Million)
TABLE 326. Australia Nuclear Medicine Software Market Size, by Functionality, 2017-2032 (USD Million)
TABLE 327. Australia Nuclear Medicine Software Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 328. Australia Nuclear Medicine Software Market Size, by Application, 2017-2032 (USD Million)
TABLE 329. Australia Nuclear Medicine Software Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 330. Australia Nuclear Medicine Software Market Size, by End User, 2017-2032 (USD Million)
TABLE 331. South Korea Nuclear Medicine Software Market Size, 2017-2032 (USD Million)
TABLE 332. South Korea Nuclear Medicine Software Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 333. South Korea Nuclear Medicine Software Market Size, by Workflow, 2017-2032 (USD Million)
TABLE 334. South Korea Nuclear Medicine Software Market Size, by Integration, 2017-2032 (USD Million)
TABLE 335. South Korea Nuclear Medicine Software Market Size, by Functionality, 2017-2032 (USD Million)
TABLE 336. South Korea Nuclear Medicine Software Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 337. South Korea Nuclear Medicine Software Market Size, by Application, 2017-2032 (USD Million)
TABLE 338. South Korea Nuclear Medicine Software Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 339. South Korea Nuclear Medicine Software Market Size, by End User, 2017-2032 (USD Million)
TABLE 340. Global Nuclear Medicine Software Market Share, by Key Player, 2025
TABLE 341. Global Nuclear Medicine Software Market, Key Experts

Companies Mentioned

  • Bracco Group
  • Canon Medical Systems Corporation
  • Comecer S.p.A.
  • Convergent Imaging Solutions
  • ec² Software Solutions
  • Esaote S.p.A.
  • Gamma Gurus Pty Ltd
  • GE Healthcare
  • Hermes Medical Solutions, Inc.
  • InMed Healthcare
  • Koninklijke Philips N.V
  • LabLogic Systems Ltd.
  • Mediso Medical Imaging Systems
  • MIM Software Inc.
  • Mirada Medical Ltd. by Sectra AB
  • Mirion Technologies Inc.
  • Segami Corporation
  • Siemens Healthineers AG
  • Syntermed Inc.
  • Winkgen Medical Systems GmbH & Co. KG

Related Topics

Related Reports

Nuclear Medicine Radioisotopes Market - Global Forecast 2026-2032 - Product Image

Nuclear Medicine Radioisotopes Market - Global Forecast 2026-2032

  • Report
  • 191 Pages
  • Global
From
Nuclear Medicine Market - Global Forecast 2026-2032 - Product Image

Nuclear Medicine Market - Global Forecast 2026-2032

  • Report
  • 183 Pages
  • Global
From
Nuclear Medicine Radioisotope - Global Strategic Business Report - Product Image

Nuclear Medicine Radioisotope - Global Strategic Business Report

  • Report
  • 186 Pages
  • Global
From
Nuclear Medicine Equipment Market Analysis and Strategic Industry Trends - Product Image

Nuclear Medicine Equipment Market Analysis and Strategic Industry Trends

  • Report
  • 135 Pages
  • Global
From
Nuclear Medicine Radioisotopes Market Outlook 2026-2034: Market Share, and Growth Analysis - Product Image

Nuclear Medicine Radioisotopes Market Outlook 2026-2034: Market Share, and Growth Analysis

  • Report
  • 160 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.